Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Norvestor in connection with the public offer for Permascand
Mandate

Vinge advises Norvestor in connection with the public offer for Permascand

December 19, 2023 M&A

Vinge has advised the principal shareholder Norvestor VI L.P in connection with the public offer by Altor PC AB to the shareholders of Permascand Top Holding AB (publ). Norvestor holds approximately 44.45 per cent of the Permascand shares and has undertaken to accept the offer. The offer values the total number of shares of Permascand at approximately SEK 1,008 million.

The Vinge team comprises Jesper Schönbeck and Linnéa Sellström.

Related

Vinge has advised Vimian Group AB in connection with its uplisting to Nasdaq Stockholm

Vinge has advised Vimian Group AB (publ) in connection with its list change from Nasdaq First North Growth Market to Nasdaq Stockholm’s main market, Large cap. The prospectus was published on 21 March 2025 and the trading on Nasdaq Stockholm commenced on 28 March 2025.
March 28, 2025

Vinge advises Tribune Therapeutics in conjunction with financing round

 Vinge advises Tribune Therapeutics, a Swedish biotechnology company focused on developing therapies for fibrotic diseases, in raising 23 MEUR. The financing round includes the previous investors HealthCap, Novo Holding and Innovestor, in addition to the new investors LifeArc Ventures, Industrifonden and Investinor.
March 26, 2025

Vinge advises Dignitana on the public offer from Paxman

 Paxman AB (publ) has announced a public offer to the shareholders of Dignitana AB. The total value of the offer is approximately SEK 153 million.
March 24, 2025